The evidence for the effectiveness of safety alerts in electronic patient medication record systems at the point of pharmacy order entry: a systematic review

BMC Medical Informatics and Decision Making (Impact Factor: 1.83). 07/2013; 13(1):69. DOI: 10.1186/1472-6947-13-69
Source: PubMed


Electronic Patient Medication Record (ePMR) systems have important safety features embedded to alert users about potential clinical hazards and errors. To date, there is no synthesis of evidence about the effectiveness of these safety features and alerts at the point of pharmacy order entry. This review aims to systematically explore the literature and synthesise published evidence about the effectiveness of safety features and alerts in ePMR systems at the point of pharmacy order entry, in primary and secondary care.
We searched MEDLINE, EMBASE, Inspec, International Pharmaceutical Abstracts, PsycINFO, CINHAL (earliest entry to March 2012) and reference lists of articles. Two reviewers examined the titles and abstracts, and used a hierarchical template to identify comparative design studies evaluating the effectiveness of safety features and alerts at the point of pharmacy order entry. The two reviewers independently assessed the quality of the included studies using Cochrane Collaboration's risk of bias tool.
Three randomised trials and two before-after studies met our criteria. Four studies involved integrated care facilities and one was hospital-based. The studies were all from the United States (US). The five studies demonstrated statistically significant reduction in medication errors in patients with renal insufficiency, pregnant women dispensed US Food Drug and Administration (FDA) risk category D (evidence of fetal risk but therapeutic benefits can outweigh the risk) or X (evidence suggests that risk to the fetus outweighs therapeutic benefits) medication, first dispensing of inappropriate medications in patients aged 65 and above, co-dispensing of interacting drugs, and adverse drug events related to hyperkalaemia.
This systematic review shows that the safety features of ePMR systems are effective in alerting users about potential clinical hazards and errors during pharmacy order entry. There are however, problems such as false alerts and inconsistencies in alert management. More studies are needed from other countries and pharmacy practice settings to assess the effectiveness of electronic safety features and alerts in preventing error and reducing harm to patients.

Download full-text


Available from: Oluwagbemileke Ojeleye, Oct 09, 2015
31 Reads
  • Source
    • "Our study design did not enable identification of subpopulations at increased risk of ADEs nor did it address the development of corrective measures. However, higher ADE rates are generally encountered in the following circumstances: lengthy hospital stay (>7 days) [40], impaired kidney function [41], elderly patients (>65 years) and multiple drug use (>8drugs on day 1) [42]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Drug-related iatrogenic effects are common in oncology because chemotherapy is toxic. The evaluation of the application of the guidelines may be a way to understand the occurrence of adverse drug-related event (ADE). There is no specific method for identifying ADEs and measuring harm to patients in oncology. Our objective was to develop and test an Oncology Trigger Tool (OTT) for ADEs and to describe ADE characteristics and incidence. A clinical advisory panel identified situations at high risk of ADE occurrence and built 22 triggers with, in each case, an analysis flowchart to confirm or refute occurrence. The OTT was used to review 288 random admissions (Oct. 2010-Sept. 2011) and measure ADE incidence and severity (CTCAE 4.03 - Common Terminology Criteria for Adverse Events). Tool feasibility (time required), inter-rater (IR) reproducibility and positive predictive value (PPV) were measured. Overall, 884 triggers were detected and 122 ADEs, with 42.4 ADEs/100 admissions or 46.0 ADEs/1000 patient-days, and a 31.1% rate of severe ADEs. The most common ADEs were hyperglycaemia (14.5%), unplanned drug-related admission within 30days (13.7%) and opiate-induced constipation (12.1%). Unplanned drug-related admission was the most serious (82.4% incidence of severe harm). Mean time for OTT implementation was 21.8min; IR reproducibility was high (κ=0.965 (trigger); κ=0.935 (ADE); κ=0.853 (harm)); PPV 22-trigger version was 20.7%. ADE analysis flowcharts coupled with standardised grading of harm considerably reduced IR variability, thus providing a robust oncology-focused trigger tool for use in ADE audits and hospital comparisons. The involvement of a clinical advisory panel in tool development should help drive changes for improving practice. Further research on the OTT is warranted. Copyright © 2014 Elsevier Ltd. All rights reserved.
    European journal of cancer (Oxford, England: 1990) 12/2014; 51(3). DOI:10.1016/j.ejca.2014.12.002 · 5.42 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Safety features embedded in electronic Patient Medication Record (ePMR) systems alert users about clinical hazards and errors in prescribed medicines during order entry. To date there has been little research about how these systems, their safety features and alerts are used to support practice; and how they are included in work processes in community pharmacies in England, UK. This study aimed to explore stakeholders' views and experiences regarding the safety features and alerts in ePMR systems; and how they might better support pharmacists and their team in practice.
    Studies in health technology and informatics 08/2013; 192:1142. DOI:10.3233/978-1-61499-289-9-1142
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Attention to ethical issues is a routine part of medical research. In this brief, we propose that health policy development, like research, should include a formal review of these issues. Ethical knowledge is, of course, a critical component of epistemology, and inherent in development of laws and principles of justice. However, we cannot assume that new policies are subject to a formal ethics review. The Belmont Report of 1978 provides a platform for this process. Prior to the Belmont Report, there was no foundation defining this process in medical research. Based on this history, we propose that health care payment policy development should include a formal assessment of risks and benefits using an approach that is familiar to all researchers.
    Journal of Gerontological Nursing 11/2013; DOI:10.3928/00989134-20131028-07 · 1.02 Impact Factor
Show more